| Regional localization within the bone marrow influences the functional capacity of human HSCs B Guezguez, CJV Campbell, AL Boyd, F Karanu, FL Casado, C Di Cresce, ... Cell stem cell 13 (2), 175-189, 2013 | 129 | 2013 |
| IDO downregulation induces sensitivity to pemetrexed, gemcitabine, FK866, and methoxyamine in human cancer cells S Maleki Vareki, D Chen, C Di Cresce, PJ Ferguson, R Figueredo, ... PloS one 10 (11), e0143435, 2015 | 43 | 2015 |
| BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis M Rytelewski, JG Tong, A Buensuceso, HS Leong, SM Vareki, ... Molecular oncology 8 (8), 1429-1440, 2014 | 38 | 2014 |
| Antisense treatment in human prostate cancer and melanoma C Di Cresce, J Koropatnick Current cancer drug targets 10 (6), 555-565, 2010 | 35 | 2010 |
| Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed C Di Cresce, R Figueredo, PJ Ferguson, MD Vincent, J Koropatnick Journal of Pharmacology and Experimental Therapeutics 338 (3), 952-963, 2011 | 32 | 2011 |
| siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine C Di Cresce, R Figueredo, M Rytelewski, SM Vareki, C Way, PJ Ferguson, ... Oncotarget 6 (26), 22397, 2015 | 9 | 2015 |
| Antisense technology: from unique laboratory tool to novel anticancer treatments C Di Cresce, C Way, M Rytelewski, SM Vareki, S Nilam, MD Vincent, ... From Nucleic Acids Sequences to Molecular Medicine, 145-189, 2012 | 4 | 2012 |
| The immunoregulatory enzyme 100 induces resistance to common chemotherapy drugs via base excision repair pathway SM Vareki, C Di, C Di Cresce, PJ Ferguson, M Vincent, W Min, X Zheng, ... CANCER IMMUNOLOGY RESEARCH 4 (1), 2016 | | 2016 |
| Abstract A134: The immunoregulatory enzyme IDO induces resistance to common chemotherapy drugs via base excision repair pathway SM Vareki, C Di, CD Cresce, PJ Ferguson, M Vincent, W Min, X Zheng, ... Cancer Immunology Research 4 (1_Supplement), A134-A134, 2016 | | 2016 |
| A BRCA2-targeting antisense oligodeoxynucleotide enhances cisplatin effectiveness by decreasing human tumor cell proliferation, metastatic frequency, and metabolic response M Rytelewski, J Tong, A Buensuceso, H Leong, P Ferguson, SM Vareki, ... Cancer Research 74 (19_Supplement), 1687-1687, 2014 | | 2014 |
| SiRNA Targeting of Thymidylate Synthase, Thymidine Kinase 1 and Thymidine Kinase 2 as a Potential Anticancer Therapy: A Combinatorial RNAi Approach C Di Cresce School of Graduate and Postdoctoral Studies, University of Western Ontario, 2014 | | 2014 |
| 49 siRNA targeting of mitochondrial thymidine kinase 2 (TK2) sensitizes cancer cells to gemcitabine and increases mitochondrial toxicity C Di Cresce, P Ferguson, R Figueredo, M Rytelewski, SM Vareki, ... European Journal of Cancer, 21, 2014 | | 2014 |
| siRNA Targeting of Thymidylate Synthase, Thymidine Kinase 1 and Thymidine Kinase 2 as an Anticancer Therapy: A Combinatorial RNAi Approach C Di Cresce The University of Western Ontario (Canada), 2014 | | 2014 |
| 191 Combining siRNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to the Anticancer Drugs 5FUdR, Pemetrexed and Gemcitabine C Di Cresce, R Figueredo, PJ Ferguson, MD Vincent, J Koropatnick European Journal of Cancer, 58, 2012 | | 2012 |
| Abstract C143: Combining siRNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5FUdR and pemetrexed. CD Cresce, R Figueredo, PJ Ferguson, MD Vincent, J Koropatnick Molecular Cancer Therapeutics 10 (11_Supplement), C143-C143, 2011 | | 2011 |
| CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY-Combining Small Interfering RNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to 5 … C Di Cresce, R Figueredo, PJ Ferguson, MD Vincent, J Koropatnick Journal of Pharmacology and Experimental Therapeutics 338 (3), 952, 2011 | | 2011 |
| Abstract C147: siRNA targeting TS and TK as an anticancer therapy C Di Cresce, R Figueredo, J Koropatnick Molecular Cancer Therapeutics 8 (12_Supplement), C147-C147, 2009 | | 2009 |
